Compare Arbitrum (ARB) vs Enzyme (MLN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Arbitrum vs Enzyme — how do they compare? Arbitrum trades at Rp1,374 (market cap Rp8,78T, Rp1,06T 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Arbitrum is far larger — about 65458.9× Enzyme's market cap, and Arbitrum's circulating supply is 6,4B ARB versus 3,3M MLN for Enzyme. Which is the better fit depends on your goals — on Pluang, investors hold Arbitrum for 61 Days and Enzyme for 28 Days on average.
| ARB | MLN | |
|---|---|---|
Market Cap | Rp8,78T | Rp134,13M |
Volume (24h) | Rp1,06T | Rp104,56M |
Circulating Supply | 6,4B ARB | 3,3M MLN |
Typical Hold Time | 61 Days | 28 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Arbitrum (ARB) is currently trading at Rp1,379 with a market cap of Rp8.86 trillion, showing bearish technical signals with 15 sell indicators versus 3 buy signals. The token faces resistance at Rp1,402 (pivot point) with support at Rp1,354. Recent ecosystem news includes Pheasant Network's $2M funding round supported by Ethereum Foundation, focusing on AI-powered cross-chain technology that could benefit Arbitrum's DeFi ecosystem.
Overall outlook remains cautious due to strong bearish technical momentum, though neutral oscillators suggest potential stabilization. Key opportunities include ecosystem growth from AI integration projects, while major risks include continued selling pressure and crypto market volatility. Investors should monitor support levels closely for potential entry points.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134.13 million and circulating supply of 3.3 million tokens. The asset demonstrates relatively low volatility with a 28-day average hold time, suggesting stable holding patterns among current investors. Trading volumes appear subdued, indicating limited market participation and liquidity depth at current levels.
Overall outlook remains cautious due to thin liquidity and limited ecosystem developments. Key opportunities include potential protocol upgrades and ecosystem expansion, while major risks center around low trading volumes and regulatory uncertainty in the cryptocurrency space. Investors should monitor network activity and exchange listings for catalysts.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Arbitrum
Arbitrum is an Ethereum layer-2 scaling solution. It uses optimistic rollups to achieve its goal of improving speed, scalability and cost-efficiency on Ethereum. Arbitrum benefits from the security and compatibility of Ethereum. Another benefit is the higher throughput and lower fees compared to Ethereum. That is made possible thanks to moving most of the computation and storage load off-chain. Arbitrum’s native token is called ARB and is used for governance. Offchain Labs, the developers behind Arbitrum, announced the shift to a decentralized autonomous organization (DAO) structure — the Arbitrum DAO. ARB holders can vote on proposals that affect the features, protocol upgrades, funds allocation and election of a Security Council.
Read more on ARB →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
